A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
Clinical trial NCT02479412 · COMPLETED
Trial details
- NCT number
- NCT02479412
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-25
- Primary completion
- 2016-02-08
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.